Brief: Synektik To Spin Off Cardiotracer, Research Segment Into New Listed Company
March 27 (Reuters) - Synektik SA SNTP.WA: RESOLVES TO DIVIDE COMPANY VIA TRANSFER COMPANY'S CARDIOTRACER AND CENTRE FOR NEW MOLECULE RESEARCH TO ANOTHER COMPANY MANAGEMENT INTENDS FOR EXISTING SHAREHOLDERS TO RECEIVE SHARES IN THE NEW COMPANY, WHICH WILL BE LISTED ON THE STOCK EXCHANGE Source text: ID:nEMbPrWWca Further company coverage: SNTP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synektik SA
See all newsBrief: Synektik Signs Contracts For Ct And Mri Systems Worth 22.5 Mln Zlotys Net
Brief: Synektik Signs Max 10.5 Mln Zloty Deal For Supply Of Da Vinci System Consumables With Krakow University Hospital
Brief: Synektik Signs Deal With Private Company In Slovakia For Sale And Installation Of Vinci 5 System
Brief: Synektik Signs 16.1 Mln Zloty Deal To Deliver Da Vinci Robotic Surgery System To Hospital In Krakow
Brief: Synektik Q4 FY2025 Medical Equipment Orders At About 70 Mln Zlotys